Bellevue Group Ag Nevro Corp Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.56 - $20.78 $841,926 - $1.29 Million	-62,089 Reduced 31.47%	135,235 $1.95 Million
Q4 2023 Feb 14, 2024	SELL	$14.18 - $22.31 $12,010 - $18,896	-847 Reduced 0.43%	197,324 $4.25 Million
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $371,724 - $527,391	-20,402 Reduced 9.33%	198,171 $3.81 Million
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $1.28 Million - $1.74 Million	-42,262 Reduced 16.2%	218,573 $7.9 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $183,132 - $238,847	-4,504 Reduced 1.7%	260,835 $12.2 Million
Q2 2022 Aug 11, 2022	BUY	$40.85 - $77.67 $1.12 Million - $2.14 Million	27,498 Added 11.56%	265,339 $11.6 Million
Q4 2021 Feb 10, 2022	BUY	$81.07 - $121.29 $1.86 Million - $2.78 Million	22,885 Added 10.65%	237,841 $19.3 Million
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $3.24 Million - $5.28 Million	31,755 Added 17.33%	214,956 $25 Million
Q2 2021 Aug 12, 2021	BUY	$141.6 - $179.06 $309,820 - $391,783	2,188 Added 1.21%	183,201 $30.4 Million
Q1 2021 May 12, 2021	BUY	$132.81 - $182.18 $6.72 Million - $9.22 Million	50,611 Added 38.81%	181,013 $25.3 Million
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $1.36 Million - $1.81 Million	9,833 Added 8.16%	130,402 $22.6 Million
Q3 2020 Nov 16, 2020	BUY	$114.09 - $145.51 $1 Million - $1.28 Million	8,807 Added 7.88%	120,569 $16.8 Million
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $2.85 Million - $4.14 Million	31,856 Added 39.87%	111,762 $13.4 Million
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $2.09 Million - $4.3 Million	-29,799 Reduced 27.16%	79,906 $7.99 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $2.71 Million - $4.16 Million	-35,406 Reduced 24.4%	109,705 $12.9 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $280,715 - $415,689	4,563 Added 3.25%	145,111 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $704,953 - $813,660	12,146 Added 9.46%	140,548 $9.11 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $1.67 Million - $2.94 Million	46,964 Added 57.67%	128,402 $8.03 Million
Q4 2018 Feb 12, 2019	BUY	$35.43 - $56.29 $36,244 - $57,584	1,023 Added 1.27%	81,438 $3.17 Million
Q3 2018 Nov 13, 2018	BUY	$44.22 - $75.47 $2.42 Million - $4.12 Million	54,617 Added 211.71%	80,415 $4.58 Million
Q2 2018 Aug 07, 2018	BUY	$72.38 - $92.5 $1.09 Million - $1.4 Million	15,098 Added 141.1%	25,798 $2.06 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $80,870 - $91,080	1,000 Added 10.31%	10,700 $972,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,700	9,700 $722,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$16.6 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.1 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$13.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.21 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$7.9 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account